Opsin Biotherapeutics
Bedford · Founded 2019
About Opsin Biotherapeutics
Opsin Biotherapeutics develops a pipeline of opsin-based gene therapies for pain management.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $327.9K
- Last round: Grant (Jul 2023)
- Website: https://opsinbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Life Science, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/opsin-biotherapeutics-103085 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.